Identifying UK travellers at increased risk of developing pneumococcal infection: a novel algorithm
Author(s) -
Gillian Ellsbury,
James Campling,
Harish Madhava,
Mary Slack
Publication year - 2021
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/taab063
Subject(s) - medicine , developing country , vaccination , epidemiology , pneumococcal disease , environmental health , developed country , population , immunology , streptococcus pneumoniae , economic growth , biology , bacteria , economics , genetics
In 2016, the travel subcommittee of the UK Joint Committee on Vaccination and Immunisation (JCVI) recommended that 13-valent PCV (PCV13) could be offered to travellers aged over 65 years, visiting countries without infant PCV immunization programmes. This study aimed to identify, collate and review the available evidence to identify specific countries where UK travellers might be at an increased risk of developing pneumococcal infection. The data were then used to develop an algorithm, which could be used to facilitate implementation of the JCVI recommendation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom